Edition:
India

China Medical System Holdings Ltd (0867.HK)

0867.HK on Hong Kong Stock

10.16HKD
15 Oct 2019
Change (% chg)

HK$-0.02 (-0.20%)
Prev Close
HK$10.18
Open
HK$10.20
Day's High
HK$10.30
Day's Low
HK$10.02
Volume
5,203,099
Avg. Vol
6,840,218
52-wk High
HK$10.92
52-wk Low
HK$6.14

Latest Key Developments (Source: Significant Developments)

Sun Pharmaceutical Industries Enters Licensing Agreement With China Medical System Holdings
Friday, 16 Aug 2019 

Aug 16 (Reuters) - Sun Pharmaceutical Industries Ltd ::SUN PHARMA AND CHINA MEDICAL SYSTEM HOLDINGS ENTER INTO LICENSING AGREEMENT FOR GENERIC PRODUCTS IN MAINLAND CHINA.TERM OF AGREEMENT TO BE 20 YEARS FROM FIRST COMMERCIAL SALE OF PRODUCTS IN MAINLAND CHINA, MAYBE EXTENDED BY 3 YRS.  Full Article

China Medical System Holdings HY Turnover Up 11.7%
Friday, 16 Aug 2019 

Aug 16 (Reuters) - China Medical System Holdings Ltd <0867.HK>::HY TURNOVER UP 11.7% TO RMB2,964.4 MILLION.HY PROFIT FOR PERIOD UP 22.2% TO RMB1,167.5 MILLION.DECLARED INTERIM DIVIDEND UP 22.6% COMPARED WITH SAME PERIOD LAST YEAR TO RMB0.1883 PER SHARE.  Full Article

China Medical System Says Unit Signs License Agreement With Unit Of Sun Pharmaceutical Industries
Thursday, 27 Jun 2019 

June 27 (Reuters) - China Medical System Holdings Ltd <0867.HK>::UNIT SIGNS A LICENSE AGREEMENT OF CYCLOSPORINE A FOR TREATMENT OF DRY EYE DISEASE WITH UNIT OF SUN PHARMACEUTICAL INDUSTRIES.  Full Article

China Medical System Signs License Agreement With Unit Of Sun Pharmaceutical Industries
Thursday, 27 Jun 2019 

June 27 (Reuters) - China Medical System Holdings Ltd <0867.HK>::SIGNED A LICENSE AGREEMENT WITH A UNIT OF SUN PHARMACEUTICAL INDUSTRIES LTD.LICENSE AGREEMENT FOR PRODUCT TILDRAKIZUMAB FOR TREATMENT OF PSORIASIS AND PSORIATIC ARTHRITIS.  Full Article

China Medical System Through Unit Signs License And Collaboration Agreement With VAXIMM AG
Wednesday, 19 Sep 2018 

Sept 19 (Reuters) - China Medical System Holdings Ltd <0867.HK>::GROUP THROUGH UNIT SIGNED LICENSE AND COLLABORATION AGREEMENT WITH VAXIMM AG.UNDER DEAL, GROUP GAINS EXCLUSIVE RIGHTS TO DEVELOP, COMMERCIALIZE CURRENT PHARMACEUTICAL PRODUCTS PORTFOLIO OF VAXIMM AG.  Full Article

China Medical System Posts FY Profit Attributable Of ‍RMB1.67 Bln
Monday, 19 Mar 2018 

March 19 (Reuters) - China Medical System Holdings Ltd <0867.HK>::FY ‍TURNOVER UP 9.1% TO RMB5,348.8 MILLION​.‍PROPOSED FINAL DIVIDEND OF RMB0.1393 PER SHARE​.FY PROFIT ATTRIBUTABLE ‍RMB1,669.9​ MILLION VERSUS RMB1,377.9 MILLION.  Full Article